Dr. Andrew Douglas, a fellow in the Drug Information Center in the College of Pharmacy, recently published an article titled “Pharmacologic Management of HCV Treatment in Patients with HCV Monoinfection vs. HIV/HCV Coinfection: Does Coinfection Really Matter?”
The article, which was published in PLOS One, originated from a poster that he presented at the ASHP Midyear Clinical Meeting in 2017. Douglas worked with a group consisting of pharmacists, statisticians and physicians through the Specialty Pharmacy and Infectious Diseases Clinic at Vanderbilt University Medical Center.
